Suwon, South Korea

Curogen Technology Co., Ltd.


USPTO Granted Patents = 4

Trademarks = 1

Forward Citations = 0

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal Chang Woo Lee (4 out of 5 patents)

silverMedal Mi-La Cho (2 out of 19 patents)

bronzeMedal Sung-Hwan Park (2 out of 11 patents)

4.  Seung-Ki Kwok (2 out of 4 patents)

5.  Jong-Young Choi (2 out of 5 patents)

6.  Seung-Hun Lee (2 out of 3 patents)

7.  Hyeon-Beom Seo (2 out of 5 patents)

8.  Young-Mee Moon (2 out of 3 patents)

9.  Jin-Sil Park (2 out of 2 patents)

10.  Jin-Kwan Lee (2 out of 2 patents)

11.  Min-Jung Park (2 out of 14 patents)

12.  Hyun Soo Kim (2 out of 115 patents)

13.  Jin Kwan Lee (2 out of 2 patents)

14.  Jae-Kyung Kim (1 out of 18 patents)

15.  Ji Hyun Choi (1 out of 1 patent)


4 patents:

Company Overview
Curogen Technology Co., Ltd. is a leading provider of innovative technology solutions for the healthcare industry. With a focus on genetic testing and precision medicine, Curogen offers a wide range of products and services to help healthcare professionals make more informed decisions for their patients. Founded in 2005, Curogen has established itself as a trusted partner in the field of genomic technology, with a track record of delivering high-quality results and personalized care.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#53 in Suwon

#2,202 in South Korea

Suwon, KR
Suwon, South Korea
Forward Citations = 0

19 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Curogen Technology Co., Ltd.. Retrieved from https://idiyas.com/company/curogen-technology-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…